Evidence map›Paper›PMID 38628851›Full record

ArticleFrontiers in public health2024

Public awareness and understanding of stem cell treatments available in Saudi Arabia and their trust in hospitals and research centers involved in stem cell research-a cross sectional study.

Doaa Aboalola, Majed Ramadan, Moayad Baadhaim, Rawiah Alsiary, Heba Badraiq, Tariq Alghamdi, Samer Zakri, Neda Aboulola, Tark Falatah, Dalal Malibari

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Doaa AboalolaKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Majed RamadanKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Moayad BaadhaimKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Rawiah AlsiaryKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Heba BadraiqKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Tariq AlghamdiKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Samer ZakriKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Neda AboulolaKing AbdulAziz University Hospital, Jeddah, Saudi Arabia.
Tark FalatahKing AbdulAziz University Hospital, Jeddah, Saudi Arabia.
Dalal MalibariKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
National Guard Health Affairs · SAKing Saud bin Abdulaziz University for Health Sciences · SAKing Abdul Aziz University Hospital · SAKing Abdullah International Medical Research Center · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Although stem cell research and therapeutic applications hold great promise for medical advancements, and have rapidly progressed globally, there remains a lack of genuine public awareness of the status of this subject in Saudi Arabia. Successful integration of stem cell therapy into healthcare relies on public awareness, understanding, and trust. Therefore, we aimed in this cross-sectional study to assess the public's knowledge, awareness, trust, support, participation, and confidence in stem cell treatments and centers involved in it. Materials and methods: A voluntary questionnaire of 20 questions was distributed randomly via social media outlets. Results: Three thousand five hundred eighty four individuals participated in the survey, with approximately half of them falling within the age range of 35-50 years (46.71%). Majority of the participants, 90.71%, would like to know more about stem cell therapy and more than half of the participants (56.94%) were unfamiliar with the idea, and a comparable proportion (50.41%) expressed concerns about the safety of stem cell therapy. A lower level of awareness, indicated by a score of 5, was evenly distributed across all age groups and genders. However, regardless of gender, older participants-especially those 50 years of age or older-tended to report higher levels of confidence, trust, and support than participants in other age groups. Moreover, trust, support, participation, and confidence score for those attained high school or less was statistically significantly lower than those attained master's or PhD degree. Of the participants, 33.57% had either received stem cell therapy themselves or known someone who had; about 24.07% of them reported that it was a cosmetic type of treatment. Conclusion: The study emphasizes the persistent need for awareness and educational initiatives to minimize the lack of public awareness and understanding of approved stem cell treatments in Saudi Arabia. It advocates for increased education, transparency, and communication to bridge knowledge gaps and enhance public trust to ensure the understanding of successful treatment.

Indexed as

Stem Cell ResearchTrustAdultCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHospitalsHumansMaleMiddle AgedSaudi Arabiaattitudeknowledgemisleading stem cell informationpublic awarenesspublic healthSaudi Arabiastem cell researchstem cell treatments

Identifiers

PMID38628851
PMCPMC11018913
OpenAlexW4393442805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.